Endothelin-1 antagonism and nitric oxide augmentation prevents cyclosporine-induced vasomotor impairment

Journal of Heart and Lung Transplantation

Volumn 30, Issue 1, 2011, Pages 77-85

  Ramzy, Danny ^a   Wallen, Jack ^a   Badiwala, Mitesh V ^a   Tumiati, Laura C ^a   Tepperman, Elissa ^a   Ross, Heather J ^a   Delgado, Diego H ^a   Rao, Vivek ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

cyclosporine; endothelium transplant; heart; nitric oxide; vascular function

Indexed keywords

8 ISOPROSTANE; ACETYLCHOLINE; BOSENTAN; CYCLOSPORIN A; ENDOTHELIN 1; NITRIC OXIDE; NITROPRUSSIDE SODIUM; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; HOMEOSTASIS; LEWIS RAT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASODILATATION; VASOMOTOR DISORDER; VASOSPASM;

ANIMALS; AUTONOMIC NERVOUS SYSTEM DISEASES; BIOPTERIN; CYCLOSPORINE; DRUG THERAPY, COMBINATION; ENDOTHELIAL CELLS; ENDOTHELIN-1; HOMEOSTASIS; MALE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, INBRED LEW; REACTIVE OXYGEN SPECIES; SULFONAMIDES; VASODILATION; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 78649964713     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.08.001     Document Type: Article

References (33)

1. M.E. Billingham Cardiac transplant atherosclerosis Transplant Proc 19 suppl 5 1987 19 25
2. C. Zoja, L. Furci, and F. Ghilardi Cyclosporin-induced endothelial cell injury Lab Invest 55 1986 455 462
3. D. Ramzy, V. Rao, and L.C. Tumiati Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine Circulation 114 suppl 2006 I-214 I-219
4. K. Sudhir, J.S. MacGregor, and T. DeMarco Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries Circulation 90 1994 3018 3023
5. D. Diederich, Z. Yang, and T.F. Luscher Chronic cyclosporine therapy impairs endothelium-dependent relaxation in the renal artery of the rat J Am Soc Nephrol 2 1992 1291 1297
6. T.M. Buetler, F. Cottet-Maire, and A. Krauskopf Does cyclosporin A generate free radicals? Trends Pharmacol Sci 21 2000 288 290
7. M. Takeda, M.D. Breyer, and T.D. Noland Endothelin-1 receptor antagonist: effects on endothelin- and cyclosporine-treated mesangial cells Kidney Int 41 1992 1713 1719
8. D. Ramzy, V. Rao, and L.C. Tumiati Tetrahydrobiopterin prevents cyclosporine-induced vasomotor dysfunction Transplantation 79 2005 876 881
9. P.W. Fedak, V. Rao, and S. Verma Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation J Thorac Cardiovasc Surg 129 2005 407 415
10. S.K. Gupta, A. Saxena, and U. Singh Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion Mol Cell Biochem 275 2005 67 74
11. A. Yamaguchi, D.N. Miniati, and K. Hirata Ex vivo blockade of endothelin-1 inhibits graft coronary artery disease in a rodent cardiac allograft model J Heart Lung Transplant 21 2002 417 424
12. A. Treiber, R. Schneiter, and S. Hausler Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil Drug Metab Dispos 35 2007 1400 1407
13. T.E. Hunley, A. Fogo, and S. Iwasaki Endothelin A receptor mediates functional but not structural damage in chronic cyclosporine nephrotoxicity J Am Soc Nephrol 5 1995 1718 1723
14. Y. Takeda, I. Miyamori, and T. Yoneda Endothelin-1 release from the mesenteric arteries of cyclosporine-treated rats Eur J Pharmacol 213 1992 445 447
15. J.M. Pearl, D.P. Nelson, and C.J. Wagner Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation Ann Thorac Surg 72 2001 565 570
16. A. Khalil, M. Carrier, and J.G. Latour Cyclosporin A-induced coronary artery vasoconstriction through myogenic and endothelium-dependent mechanisms Circulation 94 suppl 1996 II-308 11
17. T. Heitzer, K. Krohn, and S. Albers Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus Diabetologia 43 2000 1435 1438
18. O. Malo, F. Desjardins, and J.F. Tanguay Tetrahydrobiopterin and antioxidants reverse the coronary endothelial dysfunction associated with left ventricular hypertrophy in a porcine model Cardiovasc Res 59 2003 501 511
19. Y. Fukuda, H. Teragawa, and K. Matsuda Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia Heart 87 2002 264 269 (Pubitemid 34177685)
20. M. Barton, C.C. Haudenschild, and L.V. d'Uscio Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice Proc Natl Acad Sci USA 95 1998 14367 14372
21. F. Bohm, E. Beltran, and J. Pernow Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition J Intern Med 257 2005 263 271
22. A. Krauskopf, P. Lhote, and O. Petermann Cyclosporin A generates superoxide in smooth muscle cells Free Radic Res 39 2005 913 919
23. F. Hong, J. Lee, and J.W. Song Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity FASEB J 16 2002 1633 1635
24. S.Z. Gao, E.L. Alderman, and J.S. Schroeder Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings J Am Coll Cardiol 12 1988 334 340
25. K. Hoang, Y.D. Chen, and G. Reaven Diabetes and dyslipidemia A new model for transplant coronary artery disease Circulation 97 1998 2160 2168
26. M.R. Costanzo, D.C. Naftel, and M.R. Pritzker Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors J Heart Lung Transplant 17 1998 744 753
27. W.P. Faulk, C.A. Labarrere, and D. Pitts Laboratory-clinical correlates of time-associated lesions in the vascular immunopathology of human cardiac allografts J Heart Lung Transplant 12 suppl 1993 S125 S134
28. M.R. Mehra, H.O. Ventura, and R. Chambers Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study J Am Coll Cardiol 26 1995 1537 1544
29. B.F. Uretsky, S. Murali, and P.S. Reddy Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone Circulation 76 1987 827 834
30. A. Schutz, B.M. Kemkes, and C. Kugler The influence of rejection episodes on the development of coronary artery disease after heart transplantation Eur J Cardiothorac Surg 4 1990 300 307
31. A.K. Subramanian, T.C. Quinn, and T.S. Kickler Correlation of chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation Transplantation 73 2002 761 764
32. M.T. Grattan, C.E. Moreno-Cabral, and V.A. Starnes Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 261 1989 3561 3566
33. M. Weis, T.N. Kledal, and K.Y. Lin Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis Circulation 109 2004 500 505